Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 237

1.

Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries.

Kieler H, Artama M, Engeland A, Ericsson O, Furu K, Gissler M, Nielsen RB, Nørgaard M, Stephansson O, Valdimarsdottir U, Zoega H, Haglund B.

BMJ. 2012 Jan 12;344:d8012. doi: 10.1136/bmj.d8012.

2.

Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.

Chambers CD, Hernandez-Diaz S, Van Marter LJ, Werler MM, Louik C, Jones KL, Mitchell AA.

N Engl J Med. 2006 Feb 9;354(6):579-87.

3.

Risks associated with selective serotonin reuptake inhibitors in pregnancy.

Malm H, Klaukka T, Neuvonen PJ.

Obstet Gynecol. 2005 Dec;106(6):1289-96.

PMID:
16319254
4.

SSRIs and persistent pulmonary hypertension of the newborn.

Koren G, Nordeng H.

BMJ. 2011 Jan 12;344:d7642. doi: 10.1136/bmj.d7642. No abstract available.

PMID:
22240234
5.

Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data.

Oberlander TF, Warburton W, Misri S, Aghajanian J, Hertzman C.

Arch Gen Psychiatry. 2006 Aug;63(8):898-906.

PMID:
16894066
6.

Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.

Oberlander TF, Misri S, Fitzgerald CE, Kostaras X, Rurak D, Riggs W.

J Clin Psychiatry. 2004 Feb;65(2):230-7.

PMID:
15003078
7.

Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects.

Alwan S, Reefhuis J, Rasmussen SA, Olney RS, Friedman JM; National Birth Defects Prevention Study..

N Engl J Med. 2007 Jun 28;356(26):2684-92.

8.

Selective serotonin reuptake inhibitors during pregnancy and risk of stillbirth and infant mortality.

Stephansson O, Kieler H, Haglund B, Artama M, Engeland A, Furu K, Gissler M, Nørgaard M, Nielsen RB, Zoega H, Valdimarsdóttir U.

JAMA. 2013 Jan 2;309(1):48-54. doi: 10.1001/jama.2012.153812.

PMID:
23280224
9.

Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design.

Furu K, Kieler H, Haglund B, Engeland A, Selmer R, Stephansson O, Valdimarsdottir UA, Zoega H, Artama M, Gissler M, Malm H, Nørgaard M.

BMJ. 2015 Apr 17;350:h1798. doi: 10.1136/bmj.h1798. Erratum in: BMJ. 2015;350:h2235.

10.

Prenatal exposure to antidepressants and persistent pulmonary hypertension of the newborn: systematic review and meta-analysis.

Grigoriadis S, Vonderporten EH, Mamisashvili L, Tomlinson G, Dennis CL, Koren G, Steiner M, Mousmanis P, Cheung A, Ross LE.

BMJ. 2014 Jan 14;348:f6932. doi: 10.1136/bmj.f6932. Review.

11.

Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands.

Bakker MK, Kölling P, van den Berg PB, de Walle HE, de Jong van den Berg LT.

Br J Clin Pharmacol. 2008 Apr;65(4):600-6.

12.

Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes.

Lund N, Pedersen LH, Henriksen TB.

Arch Pediatr Adolesc Med. 2009 Oct;163(10):949-54. doi: 10.1001/archpediatrics.2009.164. Erratum in: Arch Pediatr Adolesc Med. 2009 Dec;163(12):1143.

PMID:
19805715
13.

Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian Mother and Child Cohort Study.

Nordeng H, van Gelder MM, Spigset O, Koren G, Einarson A, Eberhard-Gran M.

J Clin Psychopharmacol. 2012 Apr;32(2):186-94. doi: 10.1097/JCP.0b013e3182490eaf.

PMID:
22367660
15.

Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review.

Tuccori M, Testi A, Antonioli L, Fornai M, Montagnani S, Ghisu N, Colucci R, Corona T, Blandizzi C, Del Tacca M.

Clin Ther. 2009 Jun;31 Pt 1:1426-53. doi: 10.1016/j.clinthera.2009.07.009. Review.

PMID:
19698902
16.

Safety of newer antidepressants in pregnancy.

Way CM.

Pharmacotherapy. 2007 Apr;27(4):546-52. Review.

PMID:
17381382
17.

Selective serotonin reuptake inhibitors and risk for major congenital anomalies.

Malm H, Artama M, Gissler M, Ritvanen A.

Obstet Gynecol. 2011 Jul;118(1):111-20. doi: 10.1097/AOG.0b013e318220edcc.

PMID:
21646927
18.

Persistent pulmonary hypertension of the newborn and maternal use of SSRIs.

Wooltorton E.

CMAJ. 2006 May 23;174(11):1555-6. No abstract available.

19.

Selective serotonin reuptake inhibitor use during pregnancy and possible neonatal complications.

Cantor Sackett J, Weller RA, Weller EB.

Curr Psychiatry Rep. 2009 Jun;11(3):253-7. Review.

PMID:
19470288
20.

SSRI antidepressants and persistent pulmonary hypertension in newborns.

[No authors listed]

Prescrire Int. 2008 Aug;17(96):156.

PMID:
19492488

Supplemental Content

Support Center